Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The document is a detailed medical reference on skin and genetic disorders.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

Scalp skin conditions are more common in young adults and teenagers, especially males, with itching being the main complaint. The most common conditions are psoriasis and alopecia areata, and these can significantly affect a person's social life due to their psychological impact.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

Menopause can cause skin issues, and seeing a dermatologist helps.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Hair loss was the first sign of a brain-related complication in a woman with lupus, and early treatment helped her hair grow back.

Most patients with Systemic Lupus Erythematosus experience fatigue, skin issues, and joint pain.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Genetics, stress, and health issues can cause early hair greying, which affects self-esteem, and there's no cure, only hair dye.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Iron deficiency might contribute to hair loss in women.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

The document lists various dermatology topics, treatments, and diagnostic methods.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.